Synthetic biology brings meals and medicine closer together

Last week, synthetic biology companies Evolva Holding (SIX: EVE) and Abunda Nutrition agreed to extend and expand their current research collaboration, where Abunda uses Evolva’s technology platform to produce high-value food ingredients. For example, Evolva and Abunda are developing a "more ecologi...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Proteon Pharmaceuticals raises $24.6 million for rolling out bacteriophage therapies globally

News Commentary | August 13, 2021

The round was co‑led by Nutreco and Aqua‑Spark and joined by PFR Life Science, Montis Capital, Seventure Partners, and others. Proteon will use the funds for the commercialization and global rollout of its bacteriophage therapies for livestock and to develop new solutions to prevent mastitis in ... Not part of subscription

Motif FoodWorks launches its first precision-fermentation-derived ingredient

News Commentary | December 14, 2021

Ginkgo Biowork's spin‑out Motif FoodWorks launched its first commercial ingredient, Hemami, a bovine myoglobin protein that can be used as a flavor and aroma ingredient in plant‑based meat analog applications. The company produces Hemami by fermentation using an engineered strain of the yeast Pichia... Not part of subscription

Phagelux

Company Profile | February 28, 2022

Since we last spoke with Phagelux in 2018, the company split into two separate entities: Phagelux Skin Sciences, which develops products for human health, and Phagelux AgriHealth, which develops products for animal health, aquaculture, plant health, and food safety Through the acquisition of ... Not part of subscription